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Endoscopic double stenting for the treatment of 
malignant biliary and duodenal obstruction due to 
pancreatic cancer
Background In non resectable pancreatic cancer 
cases found to have duodenal stenosis, 13-20% are in the 
terminal stage when obstruction occurs. Considering 
the systemic condition and limited prognosis, it is better 
to apply minimally invasive treatment whenever possible.
Recently, endoscopic duodenal stenting DuS , which is 
also minimally invasive, is being increasingly used. In 
addition, it is referred to as double stenting, combining 
biliary stenting BS  and DuS, and it has also been 
reported. The purpose of the present study was to retro-
spectively evaluate endoscopic double stenting by endo-
scopic retrograde cholangiopancreatography-guided bili-
ary  dra inage  ERCP-BD  and by  endoscop ic 
ultrasono graphy-guided biliary drainage EUS-BD  for 
the treatment of non-resectable malignant biliary and du-
odenal obstruction.
Patients and Methods Medical records of 11 pa-
tients that underwent endoscopic double stenting from 
January 2008 to September 2012 were analyzed retro-
spectively.
Results Technical success rate was 100%, clinical 
success rate was 100%, early complication rate was 0% 
and late complication rate was 27.3% cholangitis : two, 
perforation : one . Mean survival time from double 
stenting was 76.5 67.8 days, mean patent period of the 
duodenal stent was 73.5 69.7 days, and mean patent 
period of the biliary stent was 62.6 60.4 days. Three 
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27.3%  patients were discharged mean duration of 
hospitalization, 21.3 days . All patients could take food 
orally, and mean Gastric Outlet Obstruction Scoring Sys-
tem score after double stenting was 2.2 0.9 points.
ERCP-BD and EUS-BD were done in three and eight 
patients, respectively. There was no statistically signifi-
cant difference between ERCP-BD and EUS-BD in 
terms of success rate and complication rate.
Conclusion Our study revealed that endoscopic dou-
ble stenting appears to be feasible and useful for the 
treatment of nonresectable malignant biliary and duode-
nal obstruction.
P2-41
Relationship between liver tissue viscoelasticity 
and histopathological findings analyzed by intra-
operative shearwave elastography and digital mi-
croscopy-assisted morphometry in patients with 
hepatocellular carãnoma
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Purpose : ShearWaveTM elastography SWE  is a novel, 
noninvasive method to assess liver fibrosis by measuring 
liver stiffness. This study was conducted to evaluate 
how pathological changes could have an impact on mea-
sured elasticity values in both resected hepatocellular 
carcinoma HCC  and adjacent liver tissue. Materials 
and Methods : Intraoperative SWE was performed in 7 
patients who underwent liver resection at our institu-
tion ; 7 HCCs and adjacent liver tissue were subjected to 
elastography measurements using an Aixplorer US 
system. A total of 48 circular regions of interest 
ROI : 3-8 mm in diameter  were located in HCCs 
n=37  and adjacent liver tissue n=11 , and mean stiff-
ness values were obtained from each ROI. All the his-
tological images corresponding to the 48 ROIs following 
surgery were transformed into digital microscopic images 
by a scanning system, and histological parameters, such 
and vessel areas, were quantitatively assessed. Rela-
tionships between the mean stiffness and the histological 
parameters were investigated using the mixed effect 
model. Results : By univariate analysis, the proportion 
of collagen fiber areas P=0.039 , fibrous areas 
P=0.045 , hepatocellular nuclear areas P=0.045 , and 
nuclear areas other than the hepatocellular and lympho-
plasmacytic nuclear areas P=0.039  showed statistically 
positive associations with mean stiffness values. Multi-
variate analysis indicated that the proportion of collagen 
fiber areas was the strongest pathological determinant of 
mean stiffness P=0.008 , with hepatocellular nuclear 
areas also having a significant effect P=0.049 . 
Conclusion : Fibrosis predictably affects elastography 
estimation, but hepatocellular density i.e., hepatocellu-
lar nuclear areas  also alters elastography assessment.
P2-42
Non Alcoholic Steatohepatitis ; NASH
4
NASH MtS
2008 1 2012 12
NASH12
14 6-16
BMI 26.3 22.8-37.7
35.6% 8.1-81.3 MtS 5
